| ID | Type | Location (GRCh37) | Location (GRCh38) | Length | GC content |
|---|---|---|---|---|---|
| hsa_CCDC66_0008600 | Intron-Exon-Intron | chr3:56606365-56650081 | chr3:56572337-56616053 | 977 nt | 0.4084 |
| hsa_CCDC66_0008700 | Intron-Exon-Intron | chr3:56606365-56652240 | chr3:56572337-56618212 | 376 nt | 0.3750 |
| hsa_CCDC66_0008800 | Intron-Exon-Intron | chr3:56606365-56653929 | chr3:56572337-56619901 | 1894 nt | 0.3960 |
| hsa_CCDC66_0008900 | Intron-Intron | chr3:56613717-56614919 | chr3:56579689-56580891 | 1203 nt | 0.3973 |
| hsa_CCDC66_0009000 | Intron-Intron | chr3:56621453-56624650 | chr3:56587425-56590622 | 250 nt | 0.3960 |
| hsa_CCDC66_0009100 | Intron-Exon-Intron | chr3:56622890-56628056 | chr3:56588862-56594028 | 527 nt | 0.4099 |
| hsa_CCDC66_0009200 | Intron-Exon-Intron | chr3:56626887-56628056 | chr3:56592859-56594028 | 328 nt | 0.3720 |
| hsa_CCDC66_0009300 | Intron-Exon-Intron | chr3:56626974-56628056 | chr3:56592946-56594028 | 423 nt | 0.4184 |
| hsa_CCDC66_0009800 | Exon-Exon | chr3:56626998-56627769 | chr3:56592970-56593741 | 132 nt | 0.3485 |
| hsa_CCDC66_0009900 | Intron-Exon-Intron | chr3:56626998-56632328 | chr3:56592970-56598300 | 579 nt | 0.4387 |
A study in human lung adenocarcinoma cells demonstrated that the circCCDC66 increases epithelial-mesenchymal transition and drug resistance [Huang et al. DOI:10.3390/cells11091381].